ESC 365 - Atenolol is not effective in reducing ventricular arrhythmia severity on exercise stress test in patients with catecholaminergic polymorphic ventricular tachycardia

ESC Premium Access

Atenolol is not effective in reducing ventricular arrhythmia severity on exercise stress test in patients with catecholaminergic polymorphic ventricular tachycardia

Session: Novel Knowledge in Advanced Treatment of Life Threatening Ventricular Arrhythmia

Topic: Drug Treatment of Ventricular Arrhythmias

Speaker: Mrs P. Peltenburg (Amsterdam, NL)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Mrs Puck Peltenburg

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))

0 follower

1 more presentation in this session

Combined endocardial and epicardial ventricular tachycardia ablation for ischemic and nonischemic dilated cardiomyopathy

Speaker: Doctor D. Nascimento Matos (Carnaxide, PT)

Access the full session

Novel Knowledge in Advanced Treatment of Life Threatening Ventricular Arrhythmia

Speakers: Mrs P. Peltenburg, Doctor D. Nascimento Matos

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources